CompuGroup Medical SE & Co. KGaA

  • WKN: A28890
  • ISIN: DE000A288904
  • Land: Deutschland

Nachricht vom 31.10.2019 | 12:48

CompuGroup Medical SE: Release of a capital market information

CompuGroup Medical SE / Share Buyback

31.10.2019 / 12:48
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement, concurrently Completion Announcement

CompuGroup Medical SE / Share Buyback

 

Koblenz, October 31, 2019

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement, concurrently Completion Announcement

In the period from October 28, 2019, up to and including October 30, 2019, CompuGroup Medical SE has bought back a total of 36,469 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of September 17, 2019, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on September 18, 2019. The share buyback was terminated on October 31, 2019 as per resolution of the Management Board of the same day. The overall volume of the shares bought back daily in the period from October 28, 2019, up to and including October 30, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:

Date Overall volume of shares bought back (number) Volume-weighted average stock market price
(EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice)
October 28, 2019 13,287 58.7113
October 29, 2019 16,250 57.4354
October 30, 2019 6,932 57.5406
     
     
     
In total: 36,469 57.9203
 

The total number of shares which have been bought back until the termination of the share buyback program by CompuGroup Medical SE since September 18, 2019, up to and including October 30, 2019, within the framework of the share buyback program thus amounts to 415,599 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200



31.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Anleihe der German Real Estate Capital S.A. stark überdurchschnittlich attraktiv

Die Anleihe der German Real Estate Capital S.A. weist aktuell eine Effektivverzinsung von ca. 14 % auf. Da es sich hier quasi um eine Immobilien-Anleihe handelt, ist das Anleiherisiko überschaubar. Insgesamt verfügt die German Real Estate-Gruppe über 6 Objekte, 24 Bestands- und 22 Handelsobjekte, womit eine Kombination aus stetigen Einnahmen und attraktiven Entwicklerrenditen erreicht wird. Wir stufen die Anleihe als stark überdurchschnittlich attraktiv ein.

Aktueller Webcast

home24 SE

Webcast Q2 Results 2020

14. August 2020

Aktuelle Research-Studie

Adler Modemärkte AG

Original-Research: Adler Modemärkte AG (von Sphene Capital GmbH): Buy

07. August 2020